Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNJ1 | P48048 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.33 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.32 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 4/20 | 0.31 |
| ▸ | IDH1 | O75874 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23968930 | 1.00 | KCNJ1 (0.36) | KCNJ1KCNH2SLC22A12BCAT2BCAT1 | |
| SCHEMBL23968834 | 0.89 | — | — | |
| SCHEMBL23968952 | 0.81 | CTSS (0.33) | — | |
| SCHEMBL21917432 | 0.81 | CTSS (0.33) | — | |
| SCHEMBL21917269 | 0.77 | USP8 (0.41) | — | |
| SCHEMBL23968953 | 0.76 | AR (0.41) | ARPGR | |
| SCHEMBL21917670 | 0.75 | KCNJ1 (0.34) | KCNJ1KCNH2SLC22A12BCAT2BCAT1 | |
| SCHEMBL21917087 | 0.75 | KCNJ1 (0.34) | KCNJ1KCNH2SLC22A12BCAT2BCAT1 | |
| SCHEMBL23968833 | 0.72 | KCNJ1 (0.40) | KCNJ1KCNH2SLC22A12BCAT2BCAT1 | |
| SCHEMBL23968931 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | LG CHEM, LTD. | 2021-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11165025-B2 | Compound and organic electronic element comprising same | OR10J3, ESR1, ETV6 | KCNJ1 189/4885KCNH2 199/4885SLC22A12 887/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.